Table 5 Objective response rates of first- and second-line treatments in patients who received cetuximab plus chemotherapy
From: Right- and left-sided colorectal cancers respond differently to cetuximab
Response | Fist-line treatment | Second-line treatment | ||
|---|---|---|---|---|
RSCC | LSCRC | RSCC | LSCRC | |
Total | 33 | 77 | 28 | 68 |
Best ORR | 12 (36.4) | 38 (49.4) | 2 (7.1) | 16 (23.5) |
CR | 0 (0) | 1 (1.3) | 0 (0) | 1 (1.5) |
PR | 12 (36.4) | 37 (48.1) | 2 (7.1) | 15 (22.0) |
SD | 11 (33.3) | 33 (42.8) | 16 (57.2) | 34 (50.0) |
PD | 10 (30.3) | 4 (5.2) | 10 (35.7) | 17 (25.0) |
NA | 0 (0) | 2 (2.6) | 0 (0) | 1 (1.5) |
P valuea | 0.296 | 0.085 | ||